全文获取类型
收费全文 | 22941篇 |
免费 | 1457篇 |
国内免费 | 43篇 |
学科分类
医药卫生 | 24441篇 |
出版年
2023年 | 152篇 |
2022年 | 230篇 |
2021年 | 430篇 |
2020年 | 301篇 |
2019年 | 455篇 |
2018年 | 556篇 |
2017年 | 420篇 |
2016年 | 468篇 |
2015年 | 568篇 |
2014年 | 760篇 |
2013年 | 1155篇 |
2012年 | 1694篇 |
2011年 | 1830篇 |
2010年 | 954篇 |
2009年 | 860篇 |
2008年 | 1560篇 |
2007年 | 1699篇 |
2006年 | 1570篇 |
2005年 | 1567篇 |
2004年 | 1570篇 |
2003年 | 1419篇 |
2002年 | 1407篇 |
2001年 | 233篇 |
2000年 | 160篇 |
1999年 | 195篇 |
1998年 | 265篇 |
1997年 | 229篇 |
1996年 | 159篇 |
1995年 | 179篇 |
1994年 | 159篇 |
1993年 | 119篇 |
1992年 | 112篇 |
1991年 | 84篇 |
1990年 | 68篇 |
1989年 | 74篇 |
1988年 | 63篇 |
1987年 | 61篇 |
1986年 | 44篇 |
1985年 | 66篇 |
1984年 | 63篇 |
1983年 | 54篇 |
1982年 | 61篇 |
1981年 | 58篇 |
1980年 | 33篇 |
1979年 | 35篇 |
1978年 | 22篇 |
1977年 | 20篇 |
1973年 | 19篇 |
1972年 | 18篇 |
1970年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
Toshio Kushiro Hiroshige Itakura Yoshihisa Abo Hiromi Gotou Shinji Terao Deborah L Keefe 《Hypertension research》2006,29(12):997-1005
Aliskiren is a novel orally active renin inhibitor for the treatment of hypertension. This study evaluated the antihypertensive efficacy, safety and tolerability of aliskiren in Japanese patients with hypertension. Forty hundred and fifty-five Japanese men and women with a mean sitting diastolic blood pressure of 95-110 mmHg were randomized to receive once-daily double-blind treatment for 8 weeks with aliskiren 75, 150 or 300 mg or placebo. Aliskiren produced significant, dose-dependent reductions in mean sitting diastolic blood pressure (p<0.0005 vs. placebo for each dose) and mean sitting systolic blood pressure (p<0.001 vs. placebo for each dose). The placebo-corrected reductions in mean sitting systolic/diastolic blood pressure were 5.7/4.0, 5.9/4.5 and 11.2/7.5 mmHg in the aliskiren 75, 150 and 300 mg groups, respectively. After 8 weeks' treatment, 27.8%, 47.8%, 48.2% and 63.7% of patients in the placebo and aliskiren 75, 150 and 300 mg groups, respectively, achieved a successful treatment response (diastolic blood pressure <90 mmHg and/or reduced by > or =10 mmHg from baseline; p<0.005 vs. placebo for each dose). Aliskiren treatment was well tolerated, with the incidence of adverse events reported in the active treatment groups (53-55%) being similar to that in the placebo group (50%). This study, which is the first to assess the antihypertensive efficacy and safety of aliskiren in Japanese patients with hypertension, demonstrates that the once-daily oral renin inhibitor aliskiren provides significant, dose-dependent reductions in blood pressure with placebo-like tolerability. 相似文献
5.
6.
7.
G Benton R C Thomas B G Nickerson J C McQuitty J Okikawa 《American journal of diseases of children (1960)》1989,143(6):678-681
Studies of adults suggest that metered-dose inhalers with spacers are as effective as hand-held nebulizers for bronchodilator delivery. We studied 13 children with acute asthma. They received two puffs every 2 minutes from metered-dose inhalers with spacers (range, 4 to 14 puffs) titrated until improvement stopped. Peak expiratory flow increased 34% for metered-dose inhalers with spacers after the first 2 puffs and increased 87% for metered-dose inhalers with spacers after dose titration. After titration, respiratory rate decreased by 12%, heart rate increased by 2%, and breath sounds improved in 92% of the patients. We concluded that the metered-dose inhalers with spacers are an effective device for the treatment of asthma in the pediatric emergency department and that the use of metered-dose inhalers with spacers with titration can achieve significant bronchodilation in the treatment of patients with acute asthma. 相似文献
8.
9.
Castleman disease is a rare disorder characterized by lymphoid hyperplasia which rarely manifests in children. We present 2 cases which highlight both histologic variants of this disease, and provide suggestions regarding workup and treatment with the goal of making practitioners aware of Castleman disease in the differential diagnosis of a child presenting with vague symptoms. 相似文献
10.
Seymour Solomon Brian M Grosberg Deborah I Friedman Richard B Lipton 《Journal of neuro-ophthalmology》2007,27(3):243-4; author reply 244-5